Canadian Corporate News - Biovail Reports Positive CardizemLA Launch Results.
TORONTO, ONTARIO, Apr 29, 2003 (CCNMatthews via COMTEX)
— CardizemLA Prescriptions Exceed 20,000
— Retail Pharmacy Stocking Reaches 80%
— Managed Care Negotiations Cover 90% of U.S. Lives
Most Popular
The Art Of Public Speaking: Build Connection With Your Audience
10 Jobs That Pay $30 An Hour
Public Speaking: 7 Secrets Of Great Public Speakers
3 Questions No Job Seeker Ever Wants To Be Asked?
13 Job Interview Mistakes To Avoid
Biovail Corporation (NYSE:BVF)(TSX:BVF) reported today on the progress of Cardizem(R)LA (diltiazem HCl), the recently launched once-daily controlled release medication for the treatment of hypertension. Cardizem(R)LA provides true 24-hour blood pressure coverage and delivers optimal levels of medication in the early morning when patients may be at greater risk of an adverse cardiac …
Read the rest of this article with a Free Trial at HighBeam Research.
